These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 9662049)
21. Mechanisms of disease: advanced glycation end-products and their receptor in inflammation and diabetes complications. Yan SF; Ramasamy R; Schmidt AM Nat Clin Pract Endocrinol Metab; 2008 May; 4(5):285-93. PubMed ID: 18332897 [TBL] [Abstract][Full Text] [Related]
22. Diabetes mellitus activates signal transduction pathways resulting in vascular endothelial growth factor resistance of human monocytes. Tchaikovski V; Olieslagers S; Böhmer FD; Waltenberger J Circulation; 2009 Jul; 120(2):150-9. PubMed ID: 19564559 [TBL] [Abstract][Full Text] [Related]
23. Association between endogenous secretory RAGE, inflammatory markers and arterial stiffness. Choi KM; Yoo HJ; Kim HY; Lee KW; Seo JA; Kim SG; Kim NH; Choi DS; Baik SH Int J Cardiol; 2009 Feb; 132(1):96-101. PubMed ID: 18190981 [TBL] [Abstract][Full Text] [Related]
24. Role of receptor for advanced glycation end products in cardiogenic shock. Selejan SR; Pöss J; Hewera L; Kazakov A; Böhm M; Link A Crit Care Med; 2012 May; 40(5):1513-22. PubMed ID: 22430238 [TBL] [Abstract][Full Text] [Related]
25. Plasma advanced glycation end products are decreased in obese children compared with lean controls. Sebeková K; Somoza V; Jarcusková M; Heidland A; Podracká L Int J Pediatr Obes; 2009; 4(2):112-8. PubMed ID: 18645732 [TBL] [Abstract][Full Text] [Related]
26. Advanced glycation end products upregulate angiogenic and pro-inflammatory cytokine production in human monocyte/macrophages. Pertyńska-Marczewska M; Kiriakidis S; Wait R; Beech J; Feldmann M; Paleolog EM Cytokine; 2004 Oct; 28(1):35-47. PubMed ID: 15341924 [TBL] [Abstract][Full Text] [Related]
27. Differential accumulation of advanced glycation end products in the course of diabetic retinopathy. Hammes HP; Alt A; Niwa T; Clausen JT; Bretzel RG; Brownlee M; Schleicher ED Diabetologia; 1999 Jun; 42(6):728-36. PubMed ID: 10382593 [TBL] [Abstract][Full Text] [Related]
28. [Activation of receptor for advanced glycation end products: a mechanism for monocyte-mediated inflammation in chronic renal failure]. Hou FF; Ren H; Guo ZJ; Chen PY; Liang M; Zhang X Zhonghua Yi Xue Za Zhi; 2004 Oct; 84(19):1614-9. PubMed ID: 15569456 [TBL] [Abstract][Full Text] [Related]
29. Methods for studying the binding of advanced glycated proteins to receptors for advanced glycation endproducts (AGE receptors). Thornalley PJ Methods Mol Biol; 2002; 196():49-62. PubMed ID: 12152217 [No Abstract] [Full Text] [Related]
30. The human insulin analog insulin lispro improves insulin binding on circulating monocytes of intensively treated insulin-dependent diabetes mellitus patients. Jehle PM; Fussgaenger RD; Kunze U; Dolderer M; Warchol W; Koop I J Clin Endocrinol Metab; 1996 Jun; 81(6):2319-27. PubMed ID: 8964871 [TBL] [Abstract][Full Text] [Related]
31. Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycation end products. Schmidt AM; Yan SD; Brett J; Mora R; Nowygrod R; Stern D J Clin Invest; 1993 May; 91(5):2155-68. PubMed ID: 8387541 [TBL] [Abstract][Full Text] [Related]
32. Advanced glycation end-products and advanced oxidation protein products in patients with diabetes mellitus. Kalousová M; Skrha J; Zima T Physiol Res; 2002; 51(6):597-604. PubMed ID: 12511184 [TBL] [Abstract][Full Text] [Related]
33. [Expression of receptors for advanced glycation end products at surface of peripheral blood monocytes and relationship thereof to plasma proinflammatory cytokines in patients undergoing hemodialysis]. Ren H; Hou F; Bi Y; Zhang X Zhonghua Yi Xue Za Zhi; 2002 Sep; 82(17):1168-72. PubMed ID: 12475402 [TBL] [Abstract][Full Text] [Related]
34. Presence of diabetic complications in type 1 diabetic patients correlates with low expression of mononuclear cell AGE-receptor-1 and elevated serum AGE. He CJ; Koschinsky T; Buenting C; Vlassara H Mol Med; 2001 Mar; 7(3):159-68. PubMed ID: 11471552 [TBL] [Abstract][Full Text] [Related]
35. The binding of advanced glycation end products to cell surfaces can be measured using bead-reconstituted cellular membrane proteins. Schmitt A; Nöller J; Schmitt J Biochim Biophys Acta; 2007 Jun; 1768(6):1389-99. PubMed ID: 17481574 [TBL] [Abstract][Full Text] [Related]
36. [Heparin blocks the binding of advanced glycation end products to its receptors on human monocytes]. Ren H; Hou F; Zhang X Zhonghua Nei Ke Za Zhi; 2002 Jan; 41(1):43-6. PubMed ID: 11940297 [TBL] [Abstract][Full Text] [Related]
37. Serum levels of advanced glycation end products (AGEs) are independently correlated with circulating levels of dipeptidyl peptidase-4 (DPP-4) in humans. Tahara N; Yamagishi S; Takeuchi M; Tahara A; Kaifu K; Ueda S; Okuda S; Imaizumi T Clin Biochem; 2013 Mar; 46(4-5):300-3. PubMed ID: 23219738 [TBL] [Abstract][Full Text] [Related]
38. Advanced glycosylation end products induced tissue factor expression in human monocyte-like U937 cells and increased tissue factor expression in monocytes from diabetic patients. Ichikawa K; Yoshinari M; Iwase M; Wakisaka M; Doi Y; Iino K; Yamamoto M; Fujishima M Atherosclerosis; 1998 Feb; 136(2):281-7. PubMed ID: 9543099 [TBL] [Abstract][Full Text] [Related]
39. Decreased serum endogenous secretory receptor for advanced glycation endproducts and increased cleaved receptor for advanced glycation endproducts levels in patients with atrial fibrillation. Zhao D; Wang Y; Xu Y Int J Cardiol; 2012 Jul; 158(3):471-2. PubMed ID: 22633675 [No Abstract] [Full Text] [Related]
40. Advanced glycosylation endproduct-specific receptors on human and rat T-lymphocytes mediate synthesis of interferon gamma: role in tissue remodeling. Imani F; Horii Y; Suthanthiran M; Skolnik EY; Makita Z; Sharma V; Sehajpal P; Vlassara H J Exp Med; 1993 Dec; 178(6):2165-72. PubMed ID: 8245789 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]